HOME >> MEDICINE >> NEWS
Long-term financial costs associated with prostate cancer treatment

The financial burden related to prostate cancer management over five years is substantial and sustained, according to a new study. Published in the February 1, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study reveals that the cumulative cost of prostate cancer is, on average, $42,570 over five years. Watchful waiting was the least expensive treatment while radiation and androgen deprivation therapy were the most expensive. The longitudinal study was the first to look at all related healthcare costs associated with all prostate cancer treatments cumulatively over time and for all ages and disease risks. The cost patterns also indicate that these therapies were appropriately utilized according to current guidelines for disease risk and age. Therefore some therapies are actually costly because they are being appropriately used for higher risk or older patients.

More than 200,000 men are diagnosed with prostate cancer every year in the United States, but the treatment options are controversial. For each treatment, questions about efficacy and concerns about life-altering adverse effects raise concerns about cost versus benefit. While studies often report immediate treatment costs, most ignore the impact of side effects and longer term considerations, such as relapse. Although age and individual risk play a role in treatment decisions, these are often not controlled for in cost studies. In addition, no studies compare the costs of all treatments.

Leslie S. Wilson, Ph.D., Department of Clinical Pharmacy, School of Pharmacy and School of Medicine of the University of California, San Francisco and co-investigators examined patterns of healthcare use over time and compared the interval costs of all prostate-related treatments over five and a half years of 4,553 newly diagnosed men stratified by age, risk, and ethnicity. For the first time, a study identified and included prostate cancer treatment failure and advers
'"/>

Contact: Amy Molnar
amolnar@wiley.com
John Wiley & Sons, Inc.
21-Dec-2006


Page: 1 2

Related medicine news :

1. Long-term treatment with VYVANSE, first prodrug stimulant, demonstrates significant efficacy in ADHD
2. Long-term anti-clotting therapy sweetens stenting outcomes in diabetic patients
3. Long-term aspirin use associated with reduced risk of dying in women
4. Long-term data on safety and effectiveness of antiobesity drugs needed
5. Long-term effects of non-alcoholic fatty liver disease
6. Long-term outcomes for prostate cancer show IMRT Curative: 89 percent disease-free 8 years later
7. Long-term abstinence may resolve many of the neurocognitive deficits associated with alcoholism
8. Long-term safety results released for breast cancer drugs
9. Long-term ibuprofen regimen after brain injury worsens cognition in animal study
10. Media availability: Long-term survival of heart attack patients with shock
11. Long-term estrogen therapy linked to breast cancer risk

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2020)... (PRWEB) , ... February 14, 2020 , ... ... were most bothered by excess weight, skin texture and discoloration, and lines and ... tightening and injectables. MilfordMD is offering some great specials in February specifically to ...
(Date:2/13/2020)... ... February 13, 2020 , ... The largest ... Arlington, Dulles-Aldie, Fair Oaks, Fairfax, Fredericksburg, Leesburg, and Woodbridge, as well as two ... fertility specialists have been named as Top Docs for Infertility by Northern Virginia ...
(Date:2/11/2020)... ... February 11, 2020 , ... There are many reasons ... (RBM), but the service that truly raises us above our competitors is our true ... is a board-certified Radiologist with years of clinical experience. We understand that it is ...
(Date:2/11/2020)... , ... February 11, 2020 , ... ... laboratories across North America, is pleased to announce a $5,000 grant to provide ... Services Group® (DSG) has generously donated to the Smiles for Everyone Foundation ...
(Date:2/10/2020)... ... February 11, 2020 , ... R3 Medical Training is now enrolling ... in Las Vegas. The training consists of thread lift placement on real patients for ... PDO thread lifts represent an excellent alternative currently for nonoperative facelift. The procedures are ...
Breaking Medicine News(10 mins):
(Date:2/15/2020)... ... ... Clean the World, a leader in global health dedicated to WASH (water, sanitation, ... partners has enabled them to increase customer support capacity by 600%, leading to an ... to produce 5.8 million bars in 2019 – 2 million additional bars, up from ...
(Date:2/15/2020)... LOS ANGELES (PRWEB) , ... February 14, 2020 , ... ... fill, and cooling pillow insert for a relaxing sleep experience—are excited to announce the ... has planned, developed, and shipped four different types of pillows over the last four ...
(Date:2/14/2020)... ... ... Dignitana AB , world leader in scalp cooling innovation, announced today that its ... in 2020 with Susan G. Komen®. The sponsorship extends Dignitana’s reach to hundreds of ... THAN PINK Walk® events in key Dignitana markets throughout year. , Dignitana is a ...
Breaking Medicine Technology:
Cached News: